katanosin b has been researched along with acetylglucosamine in 1 studies
Studies (katanosin b) | Trials (katanosin b) | Recent Studies (post-2010) (katanosin b) | Studies (acetylglucosamine) | Trials (acetylglucosamine) | Recent Studies (post-2010) (acetylglucosamine) |
---|---|---|---|---|---|
19 | 0 | 6 | 5,674 | 31 | 2,001 |
Protein | Taxonomy | katanosin b (IC50) | acetylglucosamine (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 1.9953 | |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 2.5119 | |
Killer cell lectin-like receptor subfamily B member 1A | Rattus norvegicus (Norway rat) | 2.2536 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maki, H; Miura, K; Yamano, Y | 1 |
1 other study(ies) available for katanosin b and acetylglucosamine
Article | Year |
---|---|
Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.
Topics: Acetylglucosamine; Anti-Bacterial Agents; Cell Wall; Cells, Cultured; Depsipeptides; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2001 |